KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 126 filers reported holding KALA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $25,000 | -68.4% | 114,308 | -56.3% | 0.00% | – |
| Q2 2022 | $79,000 | -95.3% | 261,744 | -78.6% | 0.00% | – |
| Q1 2022 | $1,690,000 | +25.1% | 1,224,965 | +9.7% | 0.00% | – |
| Q4 2021 | $1,351,000 | -53.6% | 1,116,291 | +0.4% | 0.00% | – |
| Q3 2021 | $2,913,000 | -33.2% | 1,111,688 | +35.2% | 0.00% | – |
| Q2 2021 | $4,358,000 | -7.6% | 822,294 | +17.5% | 0.00% | – |
| Q1 2021 | $4,716,000 | -3.1% | 699,746 | -2.5% | 0.00% | – |
| Q4 2020 | $4,867,000 | -12.4% | 717,778 | -3.1% | 0.00% | – |
| Q3 2020 | $5,556,000 | -28.8% | 740,754 | -0.2% | 0.00% | -100.0% |
| Q2 2020 | $7,803,000 | +107.2% | 742,394 | +73.3% | 0.00% | – |
| Q1 2020 | $3,766,000 | +181.3% | 428,414 | +18.1% | 0.00% | – |
| Q4 2019 | $1,339,000 | +9.0% | 362,838 | +12.5% | 0.00% | – |
| Q3 2019 | $1,228,000 | -27.6% | 322,639 | +21.4% | 0.00% | – |
| Q2 2019 | $1,696,000 | -7.9% | 265,855 | +19.4% | 0.00% | – |
| Q1 2019 | $1,841,000 | +85.4% | 222,566 | +9.6% | 0.00% | – |
| Q4 2018 | $993,000 | -48.5% | 203,014 | +3.8% | 0.00% | – |
| Q3 2018 | $1,929,000 | -27.1% | 195,643 | +1.5% | 0.00% | – |
| Q2 2018 | $2,647,000 | -17.6% | 192,795 | -5.0% | 0.00% | – |
| Q1 2018 | $3,213,000 | +107.4% | 202,895 | +142.6% | 0.00% | – |
| Q4 2017 | $1,549,000 | +20.5% | 83,634 | +48.5% | 0.00% | – |
| Q3 2017 | $1,286,000 | – | 56,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,333,333 | $5,073,000 | 100.00% |
| CAXTON CORP | 1,483,343 | $5,644,000 | 6.36% |
| Polaris Venture Management Co. V, L.L.C. | 1,197,032 | $4,555,000 | 2.59% |
| RA Capital Management | 4,537,478 | $17,265,000 | 1.03% |
| Orbimed Advisors | 3,447,840 | $13,119,000 | 0.25% |
| Matisse Capital | 46,500 | $177,000 | 0.22% |
| PURA VIDA INVESTMENTS, LLC | 332,831 | $1,266,000 | 0.22% |
| Sofinnova Investments, Inc. | 478,206 | $1,819,000 | 0.16% |
| HARBOURVEST PARTNERS LLC | 99,186 | $377,000 | 0.16% |
| ALGERT GLOBAL LLC | 47,195 | $180,000 | 0.07% |